ICCC
Price
$6.52
Change
-$0.23 (-3.41%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
61M
28 days until earnings call
NKTX
Price
$1.80
Change
-$0.01 (-0.55%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
128.43M
28 days until earnings call
Interact to see
Advertisement

ICCC vs NKTX

Header iconICCC vs NKTX Comparison
Open Charts ICCC vs NKTXBanner chart's image
ImmuCell
Price$6.52
Change-$0.23 (-3.41%)
Volume$146
Capitalization61M
Nkarta
Price$1.80
Change-$0.01 (-0.55%)
Volume$3.29K
Capitalization128.43M
ICCC vs NKTX Comparison Chart in %
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICCC vs. NKTX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Hold and NKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ICCC: $6.75 vs. NKTX: $1.81)
Brand notoriety: ICCC and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 87% vs. NKTX: 70%
Market capitalization -- ICCC: $61M vs. NKTX: $128.43M
ICCC [@Biotechnology] is valued at $61M. NKTX’s [@Biotechnology] market capitalization is $128.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than ICCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 2 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • ICCC’s TA Score: 2 bullish, 6 bearish.
  • NKTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than ICCC.

Price Growth

ICCC (@Biotechnology) experienced а +5.63% price change this week, while NKTX (@Biotechnology) price change was +4.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

ICCC is expected to report earnings on Aug 07, 2025.

NKTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($128M) has a higher market cap than ICCC($61M). ICCC YTD gains are higher at: 31.068 vs. NKTX (-27.711). ICCC has higher annual earnings (EBITDA): 2.94M vs. NKTX (-122.8M). NKTX has more cash in the bank: 266M vs. ICCC (4.6M). ICCC has less debt than NKTX: ICCC (14.7M) vs NKTX (78.9M). ICCC has higher revenues than NKTX: ICCC (27.3M) vs NKTX (0).
ICCCNKTXICCC / NKTX
Capitalization61M128M48%
EBITDA2.94M-122.8M-2%
Gain YTD31.068-27.711-112%
P/E RatioN/AN/A-
Revenue27.3M0-
Total Cash4.6M266M2%
Total Debt14.7M78.9M19%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCNKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEOJF8.56N/A
N/A
Stora Enso Oyj
MAORF2.20N/A
N/A
Mandarin Oriental International Ltd.
STBK10.00N/A
N/A
Studio Financial Holdings, Inc.
SLVMF0.11N/A
N/A
Silver Mines Ltd., Sydney
TBXXF0.15-0.01
-6.72%
King Copper Discovery Corp

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
+1.81%
NKTX - ICCC
43%
Loosely correlated
+1.69%
BOLT - ICCC
26%
Poorly correlated
+2.98%
JANX - ICCC
24%
Poorly correlated
+4.25%
TRAW - ICCC
24%
Poorly correlated
N/A
NERV - ICCC
24%
Poorly correlated
+5.04%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-0.55%
CRBU - NKTX
52%
Loosely correlated
-0.57%
BEAM - NKTX
50%
Loosely correlated
+2.66%
FATE - NKTX
49%
Loosely correlated
+0.87%
TERN - NKTX
48%
Loosely correlated
-0.41%
IPSC - NKTX
47%
Loosely correlated
-1.20%
More